 | • レポートコード：MRC2303I0079 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥665,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,225,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の歯科用バイオマテリアル市場規模が、2021年に6,464.75百万ドルとなり、2027年に9,487.13百万ドルに達する見込みです。また、予測期間中（2022年〜2027年）に年平均3.51%で成長すると予測しています。本レポートは、歯科用バイオマテリアルの世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別（金属バイオマテリアル、セラミックバイオマテリアル、ポリマーバイオマテリアル、天然バイオマテリアル、その他）分析、用途別（矯正歯科、補綴、その他）分析、エンドユーザー別（病院＆診療所、学術＆研究機関、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などを以下の構成でまとめています。また、GC Corporation、Victrex PLC、Medtronic PLC、Straumann Holding AG、ZimVie Inc.、Dentsply Sirona Inc.、Royal DSM、Danaher Corporation、3M Company、Bay Materials、Vannini Dental Industry SRL、Kyocera Corporation、Botiss Biomaterials GmbHなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の歯科用バイオマテリアル市場規模：種類別 - 金属バイオマテリアルの市場規模 - セラミックバイオマテリアルの市場規模 - ポリマーバイオマテリアルの市場規模 - 天然バイオマテリアルの市場規模 - その他種類の市場規模 ・世界の歯科用バイオマテリアル市場規模：用途別 - 矯正歯科用バイオマテリアルの市場規模 - 補綴用バイオマテリアルの市場規模 - その他用途のバイオマテリアル市場規模 ・世界の歯科用バイオマテリアル市場規模：エンドユーザー別 - 病院＆診療所における市場規模 - 学術＆研究機関における市場規模 - その他エンドユーザーにおける市場規模 ・世界の歯科用バイオマテリアル市場規模：地域別 - 北米の歯科用バイオマテリアル市場規模 アメリカの歯科用バイオマテリアル市場規模 カナダの歯科用バイオマテリアル市場規模 メキシコの歯科用バイオマテリアル市場規模 … - ヨーロッパの歯科用バイオマテリアル市場規模 ドイツの歯科用バイオマテリアル市場規模 イギリスの歯科用バイオマテリアル市場規模 フランスの歯科用バイオマテリアル市場規模 … - アジア太平洋の歯科用バイオマテリアル市場規模 中国の歯科用バイオマテリアル市場規模 日本の歯科用バイオマテリアル市場規模 インドの歯科用バイオマテリアル市場規模 … - 中東/南米の歯科用バイオマテリアル市場規模 南アフリカの歯科用バイオマテリアル市場規模 ブラジルの歯科用バイオマテリアル市場規模 アルゼンチンの歯科用バイオマテリアル市場規模 … - その他地域の歯科用バイオマテリアル市場規模 ・競争状況 ・市場機会・将来の動向 |
The dental biomaterials market was valued at about USD 6,464.75 million in 2021, and it is expected to reach USD 9,487.13 million by 2027, recording a CAGR of 6.77% over the forecast period 2022-2027.
The impact of the COVID-19 pandemic on the market was significant as several elective procedures, including dental treatments, were halted or postponed during the pandemic. In March 2020, the American Dental Association (ADA) recommended postponing all elective dental procedures until April 6, 2020, and providing emergency-only dental services to keep patients from burdening hospital emergency departments. This recommendation was updated on April 1, 2020, when the ADA advised offices to remain closed except for urgent and emergency procedures until April 30, owing to the rise of COVID-19 cases. As a result, access to dental care substantially decreased. Also, as per data published by the British Dental Association, in July 2020, out of 2,053 dentists, only 36% were ready to resume dental practices in the United Kingdom. During the initial phase of the pandemic, dental services and treatments were delayed, which resulted in decreased demand for dental biomaterials and affected market growth adversely. However, the market is gaining traction as elective dental procedures have resumed worldwide owing to the declining severity and infections of COVID-19.
Further, the major factors fueling the market growth include the rising burden of dental disorders, growing dental tourism, growing penetration of dental implants, and increasing disposable income across developing countries.
The rising burden of dental disorders and growing dental tourism are major factors driving the market growth. The growing burden of dental diseases such as periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, among other diseases, is driving the market growth. For instance, as per a March 2020 update by the World Health Organization (WHO), it is estimated that oral diseases affect nearly 3.5 billion people globally, especially severe periodontal (gum) disease. Also, an article titled “Dental Tourism 2021: Get Cheaper Dental Implants and Veneers Abroad,” published in Dentaly.org in December 2021, stated that dental implant tourism is a growing business attributed to cost savings. Such factors are thereby increasing the adoption of dental procedures among patients and are expected to drive the demand for dental biomaterials over the coming years.
Nevertheless, regulatory issues and the cost of procedures are some of the factors restraining the market growth.
Dental Biomaterials Market Trends
Metallic Biomaterials Segment Expected to Witness High Growth over the Forecast Period
By type, metallic biomaterials are expected to witness significant growth. Metallic biomaterials are a central class of materials for use in dental treatments. This can be attributed to the high strength and other mechanical properties associated with these materials. These biomaterials are extensively used to fabricate surgical implants owing to load-bearing characteristics and fatigue properties, such as titanium, gallium, and silicon.
As per an article published in November 2021, titled “Editorial: Metallic Biomaterials for Medical Applications,” titanium alloys are widely used for dental and implant materials due to their superior biocompatibility, corrosion resistance, and specific strength compared with other metallic implant materials. In addition, as per an article titled, “Review of Metallic Biomaterials in Dental Applications,” published in August 2020, Ti–Ga–Si is considered to combine the advantages of the Ti–Ga alloy along with Si, which enhances the osseointegration with aesthetically pleasing outcomes for patients and minimal likelihood of medical complications.
Such studies indicate the efficacy of metallic biomaterials and are expected to generate significant demand for metallic implants, thus positively impacting the segment’s growth.
North America Expected to Witness High Growth over the Forecast Period
Within North America, the United States is expected to observe significant growth. With the increase in product launches supported by government authorities, the rising burden of dental diseases and the increasing geriatric population are bolstering the demand for dental biomaterials in the United States.
For instance, as per the American Dental Association, in 2020, more than 5 million US seniors aged 65 to 74 had complete tooth loss, with nearly 3 million suffering from edentulous. Tooth loss, on the other hand, is primarily a problem for the elderly. This is because 91% of adults aged 20 to 64 have dental caries, with a staggering 27% going untreated. Furthermore, tooth decay is a common cause of tooth loss in many cases. Thus, such factors are anticipated to boost the total dental procedures performed across the United States, thereby boosting the demand for dental biomaterials within the country.
Furthermore, several market players are also engaged in implementing strategic initiatives, thereby propelling market growth. For instance, in January 2020, Pulpdent Corporation, a dental research and manufacturing company based in the Greater Boston area, launched its ACTIVA Presto dental material. The new white dental filling material mimics the properties of natural teeth. Moreover, in April 2021, Ultradent Products Inc., a developer and manufacturer of high-tech dental materials and equipment, purchased majority ownership in Vamasa SA de CV, a premier distributor of dental products in Mexico.
Thus, in view of the abovementioned factors, the market is expected to witness significant growth in the region over the forecast period.
Dental Biomaterials Market Competitor Analysis
The dental biomaterials market is moderately competitive, with the presence of local and international players in the market. The major share of the market has been grabbed by global players, whereas small to mid-sized companies are posing intense competition with the help of novel technologies. In the future, it is expected that the market share will be distributed among international players and small players as well due to the focus of new entrants to come up with innovative products. Some of the major players in the market are Straumann Holding AG, Dentsply Sirona Inc., 3M Company, ZimVie Inc., and Botiss Biomaterials GmbH.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Dental Disorders and Growing Dental Tourism
4.2.2 Increasing Penetration of Dental Implants
4.2.3 Increase in Disposable Incomes across Developing Countries
4.3 Market Restraints
4.3.1 Regulatory Isssues
4.3.2 Cost of the Procedure
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 By Type
5.1.1 Metallic Biomaterials
5.1.1.1 Titanium
5.1.1.2 Stainless Steel
5.1.1.3 Chromium Alloys
5.1.1.4 Other Metallic Biomaterials
5.1.2 Ceramic Biomaterials
5.1.3 Polymeric Biomaterials
5.1.4 Natural Biomaterials
5.1.5 Other Types
5.2 By Application
5.2.1 Orthodontics
5.2.2 Prosthodontics
5.2.3 Other Applications
5.3 By End User
5.3.1 Hospitals and Clinics
5.3.2 Academies and Research Institutes
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 GC Corporation
6.1.2 Victrex PLC
6.1.3 Medtronic PLC
6.1.4 Straumann Holding AG
6.1.5 ZimVie Inc.
6.1.6 Dentsply Sirona Inc.
6.1.7 Royal DSM
6.1.8 Danaher Corporation
6.1.9 3M Company
6.1.10 Bay Materials
6.1.11 Vannini Dental Industry SRL
6.1.12 Kyocera Corporation
6.1.13 Botiss Biomaterials GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS